Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.55    0.00 (0.00%)
Bid:
1.55
Ask:
1.93
Spread: 0.38 (24.516%)
Market Cap: £5.44m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Directorate Change

30 Sep 2014 07:00

RNS Number : 9286S
Proteome Sciences PLC
30 September 2014
 



 

 

 

 

 

Proteome Sciences plc

("Proteome Sciences" or the "Company")

Appointment of new Finance Director

 

30th September, 2014 - The Board of Proteome Sciences is pleased to announce the appointment of Mr. Geoffrey Ellis as Finance Director with effect from 1st October. Mr. Geoffrey John Ellis, 53, is a chartered accountant with over 30 years' experience in a range of senior financial, operational, sales and business development roles. He spent 15 years at Walt Disney where he was Chief Financial Officer of the Network of Disney Channels in EMEA and Managing Director of Disney Chanel Scandinavia, Middle East and Emerging Markets.

In addition to a strong financial background, he brings considerable international sales, marketing and licensing expertise and a key part of his role will be managing and expanding our commercial sales and marketing in USA and Europe.

Mr. James Malthouse will remain as a director of the company until his retirement on 30th November, 2014.

Mr. Ellis was a director of Curzon ISC Limited until shortly before it was placed into voluntary liquidation in March 2011. He was also a director of Warren Close Residents Association (Esher) Limited at the time it was placed into voluntary liquidation in May 2013.

Other than disclosed above, the Company confirms that there is no further information required to be disclosed in accordance with paragraph (g) of Schedule 2 of the AIM Rules.

 

- Ends -

For further information please contact:

Proteome Sciences plc

Christopher Pearce, Executive Chairman

Dr. Ian Pike, Chief Operating Officer Tel: +44 (0)1932 865065

James Malthouse, Finance Director

 

Cenkos - Nominated Adviser

Stephen Keys/Mark Connelly /Callum Davidson Tel: +44 (0)20 7397 8900

 

finnCap - Joint Broker

Geoff Nash (Corporate Finance) Tel: +44 (0)20 7220 0500

Tony Quirke (Broking)

 

IKON Associates - Public Relations

Adrian Shaw Tel: +44 (0)1483 271291

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAVKLFLZKFFBBX
Date   Source Headline
4th Dec 20084:36 pmRNSPrice Monitoring Extension
7th Nov 200811:05 amRNSChange of NOMAD
31st Oct 200812:10 pmRNSTotal Voting Rights
28th Oct 200812:36 pmRNSBlocklisting Interim Review
22nd Oct 20084:42 pmRNSSecond Price Monitoring Extn
22nd Oct 20084:37 pmRNSPrice Monitoring Extension
20th Oct 20089:38 amRNSHolding(s) in Company
13th Oct 200810:54 amRNSHolding(s) in Company
8th Oct 20082:58 pmPRNChange of Adviser Name
1st Oct 20084:41 pmRNSSecond Price Monitoring Extn
1st Oct 20084:37 pmRNSPrice Monitoring Extension
30th Sep 20087:00 amRNSInterim Results
30th Sep 20087:00 amPRNInterim Results
16th Sep 20084:48 pmRNSSecond Price Monitoring Extn
16th Sep 20084:43 pmRNSPrice Monitoring Extension
5th Aug 20083:37 pmPRNHolding(s) in Company
1st Aug 20084:40 pmRNSSecond Price Monitoring Extn
1st Aug 20084:35 pmRNSPrice Monitoring Extension
31st Jul 20084:13 pmPRNDirector Dealing
30th Jul 20084:40 pmRNSSecond Price Monitoring Extn
30th Jul 20084:35 pmRNSPrice Monitoring Extension
28th Jul 20081:58 pmPRNResult of AGM and Update
2nd Jul 20083:42 pmPRNNotifiable Interest
27th Jun 20089:50 amPRNAnnual Report and Accounts
24th Jun 20087:05 amPRNLoan Agreement
24th Jun 20087:00 amPRNFinal Results
12th Jun 20087:00 amPRNNotice of Allowance for US Patent
20th May 20082:43 pmPRNHolding(s) in Company
8th May 20087:00 amPRNSENS-IT-IV Framework 6 EU Grant Award
25th Apr 20082:30 pmPRNBlocklisting - Interim Review
17th Apr 200810:28 amPRNTotal Voting Rights
1st Apr 20083:20 pmPRNHolding(s) in Company
20th Mar 200812:22 pmPRNTMT Patent Update
13th Mar 20082:55 pmPRNHolding(s) in Company
13th Mar 20082:52 pmPRNHolding(s) in Company
20th Feb 20082:26 pmPRNHolding(s) in Company
18th Feb 200812:25 pmPRNHolding(s) in Company
14th Feb 20085:45 pmPRNHolding(s) in Company
13th Feb 20083:04 pmPRNHolding(s) in Company
5th Feb 20088:36 amPRNStatement re Share Price Movement
23rd Jan 20084:21 pmPRNHolding(s) in Company
18th Jan 20083:53 pmPRNHolding(s) in Company
21st Dec 20077:00 amPRNCurrent Trading
20th Nov 20075:24 pmPRNNotifiable Interests
20th Nov 20075:01 pmPRNNotifiable Interest
19th Nov 20074:33 pmPRNNotifiable Interest (TR-1)
13th Nov 20075:38 pmPRNStatement re Issuance of US Patent
5th Nov 20073:57 pmPRNNotifiable Interest
31st Oct 20077:00 amPRNBlocklisting - Interim Review
10th Oct 20073:31 pmPRNNotifiable Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.